Medicine News

Digital Health Intervention to Maintain Your Brain

14 October 2019
Target Sites: 
Medicine (select for all events)
CHeBA2 (Please do not publish without approval prior)
School of Psychiatry
CHeBA News: Digital Health Intervention to Maintain Your Brain

HEIDI DOUGLASS | h.douglass@unsw.edu.au

3DN Staff at Down Syndrome NSW Health Conference

27 September 2019
Target Sites: 
Department of Developmental Disability Neuropsychiatry (Please do not publish without approval prior)

Julian Trollor and Liz Evans gave a talk at the Down syndrome NSW Health conference. The topic of the talk was dementia in people with Down syndrome, and focused on both why people with Down syndrome have a high risk of dementia, as well as what steps can be taken to promote healthy ageing in people with Down syndrome.

Education Program Improves Care Quality in Aged Care

9 October 2019
Target Sites: 
Medicine (select for all events)
CHeBA2 (Please do not publish without approval prior)
School of Psychiatry
CHeBA News: Education Program Improves Care Quality in Aged Care

HEIDI DOUGLASS | h.douglass@unsw.edu.au

An education program led by Professor Lynn Chenoweth at the Centre for Healthy Brain Ageing (CHeBA), UNSW Sydney has resulted in significant improvement in care service quality by promoting better understanding, relationships and collaboration between family members and direct care staff.

International trial uncovers crucial gaps in our understanding of influenza therapies

9 October 2019
Target Sites: 
The Kirby Institute (Please do not publish without approval prior)
Contact Name: 
Luci Bamford, Media and Communications Manager, Kirby Institute

A major international clinical trial conducted by researchers at the Kirby Institute at UNSW Sydney in collaboration with global partners in the INSIGHT network has found that a treatment that was long assumed to improve the health of people with severe influenza infections, in fact, provides no clear clinical benefit. The results of the trial were published in The Lancet Respiratory and have revealed crucial gaps in our understanding of immunotherapies to treat influenza.

More accurate diagnosis for rare ovarian cancer type on the cards, new research reveals

3 October 2019
Target Sites: 
Medicine (select for all events)
Contact Name: 
Isabelle Dubach
The researchers found that the new biomarker - when it's used in combination with another, established marker - increased the accuracy of the diagnosis.

UNSW medical researchers have shown how a biomarker could help doctors more accurately diagnose one of the rarest types of ovarian cancer.

A biomarker could help doctors more accurately diagnose mucinous ovarian cancer – one of the rarest types of the insidious disease, UNSW medical researchers have revealed. Down the track, better diagnosis is hoped to help reduce some of the misclassification that occurs and better inform the treatment options for these women.

Pages